Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00512135
Status:
COMPLETED
Last Update Posted:
2021-04-02
First Post:
2007-08-06
Brief Title:
Safety and Efficacy of NT 201 IncobotulinumtoxinA Xeomin in the Treatment of Glabellar Frown Lines
Sponsor:
Merz Pharmaceuticals GmbH
Organization:
Merz Pharmaceuticals GmbH
Organization Data
Organization:
Merz Pharmaceuticals GmbH
Class:
INDUSTRY
Study ID:
MRZ 60201-06091
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Merz Pharmaceuticals GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None